{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:16:04Z","timestamp":1790118964591,"version":"4.0.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1007\/s007020170091","type":"journal-article","created":{"date-parts":[[2003,2,12]],"date-time":"2003-02-12T18:05:56Z","timestamp":1045073156000},"page":"231-246","source":"Crossref","is-referenced-by-count":33,"title":["Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer\u2019s disease patients"],"prefix":"10.1007","volume":"108","author":[{"given":"N.","family":"R\u00f6sler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Wichart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. A.","family":"Jellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"11080231702_CR1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archneur.56.6.673","volume":"56","author":"N Andreasen","year":"1999","unstructured":"Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K (1999a) Cerebrospinal fluid \u03b2-amyloid(1\u201342) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol 56: 673\u2013680","journal-title":"Arch Neurol"},{"key":"11080231702_CR2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(99)00617-5","volume":"273","author":"N Andreasen","year":"1999","unstructured":"Andreasen N, Minthon L, Vanmechelen E, Vanderstichele H, Davidsson P, Winblad B, Blennow K (1999b) Cerebrospinal fluid tau and A\u03b242 as predictors of development of Alzheimer\u2019s disease in patients with mild cognitive impairment. Neurosci Lett 273: 5\u20138","journal-title":"Neurosci Lett"},{"issue":"[Suppl] 1","key":"11080231702_CR3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000213879","volume":"43","author":"H Arai","year":"1997","unstructured":"Arai H, Higuchi S, Sasaki H (1997) Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer\u2019s disease. Gerontology 43 [Suppl] 1: 2\u201310","journal-title":"Gerontology"},{"issue":"Suppl","key":"11080231702_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-7091-6467-9_17","volume":"53","author":"C Bancher","year":"1998","unstructured":"Bancher C, Jellinger K, Wichart I (1998) Biological markers for the diagnosis of Alzheimer\u2019s disease. J Neural Transm [Suppl] 53: 185\u2013197","journal-title":"J Neural Transm"},{"key":"11080231702_CR5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-5793(91)80737-N","volume":"285","author":"J Bauer","year":"1991","unstructured":"Bauer J, Strauss S, Schreiter-Gasser U, Ganter U, Schlegel P, Witt I, Volk B, Berger M (1991) Interleukin-6 and \u03b12-macroglobulin indicate an acute-phase state in Alzheimer\u2019s disease cortices. FEBS Lett 285: 111\u2013114","journal-title":"FEBS Lett"},{"key":"11080231702_CR6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archneur.55.3.294","volume":"55","author":"D Blacker","year":"1998","unstructured":"Blacker D, Tanzi RE (1998) The genetics of Alzheimer\u2019s disease \u2013 current status and future prospects. Arch Neurol 55: 294\u2013296","journal-title":"Arch Neurol"},{"issue":"Suppl","key":"11080231702_CR7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-3-7091-6467-9_20","volume":"53","author":"K Blennow","year":"1998","unstructured":"Blennow K, Vanmechelen E (1998) Combination of the different biological markers for increasing specificity of in vivo Alzheimer\u2019s testing. J Neural Transm [Suppl] 53: 223\u2013235","journal-title":"J Neural Transm"},{"key":"11080231702_CR8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00002093-199040200-00002","volume":"4","author":"K Blennow","year":"1990","unstructured":"Blennow K, Wallin A, Davidsson P, Fredman P, Gottfries CG, Svennerholm L (1990) Intra-blood-brain-barrier synthesis of immunoglobulins in patients with dementia of the Alzheimer type. Alzheimer Dis Assoc Disord 4: 79\u201386","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"11080231702_CR9","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1097\/00001756-199412000-00032","volume":"5","author":"K Blennow","year":"1994","unstructured":"Blennow K, Hesse C, Fredman P (1994) Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer\u2019s disease. Neuroreport 5: 2534\u20132536","journal-title":"Neuroreport"},{"key":"11080231702_CR10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","volume":"202","author":"D Blum-Degen","year":"1995","unstructured":"Blum-Degen D, M\u00fcller T, Kuhn W, Gerlach M, Przuntek H, Riederer P (1995) Interleukin-1\u03b2 and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients. Neurosci Lett 202: 17\u201320","journal-title":"Neurosci Lett"},{"key":"11080231702_CR11","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.1073\/pnas.90.21.10061","volume":"90","author":"IL Campbell","year":"1993","unstructured":"Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MBA, Mucke L (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6. Proc Natl Acad Sci USA 90: 10061\u201310065","journal-title":"Proc Natl Acad Sci USA"},{"key":"11080231702_CR12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0009-8981(91)90070-S","volume":"196","author":"J Carlsson","year":"1991","unstructured":"Carlsson J, Armstrong VW, Reiber H, Felgenhauer K, Seidel D (1991) Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin Chim Acta 196: 167\u2013176","journal-title":"Clin Chim Acta"},{"key":"11080231702_CR13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0197-4580(98)00022-0","volume":"19","author":"Consensus Report of the Working Group","year":"1998","unstructured":"Consensus Report of the Working Group on: \u201cMolecular and Biochemical Markers of Alzheimer\u2019s Disease\u201d (1998) Neurobiol Aging 19: 109\u2013116","journal-title":"Neurobiol Aging"},{"key":"11080231702_CR14","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s000180050223","volume":"54","author":"EH Corder","year":"1998","unstructured":"Corder EH, Lannfelt L, Bogdanovic N, Fratiglioni L, Mori H (1998) The role of apoe polymorphisms in late-onset dementias. Cell Molec Life Sci 54: 928\u2013934","journal-title":"Cell Molec Life Sci"},{"key":"11080231702_CR15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF00313833","volume":"232","author":"H Cramer","year":"1985","unstructured":"Cramer H, Schaudt D, Rissler K, Strubel D, Warter JM, Kuntzmann F (1985) Somatostatin-like immunoreactivity and substance P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus. J Neurol 232: 346\u2013351","journal-title":"J Neurol"},{"key":"11080231702_CR16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005072-199704000-00001","volume":"56","author":"DW Dickson","year":"1997","unstructured":"Dickson DW (1997) The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56: 321\u2013329","journal-title":"J Neuropathol Exp Neurol"},{"key":"11080231702_CR17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0197-0186(99)00031-5","volume":"34","author":"S Engelborghs","year":"1999","unstructured":"Engelborghs S, De Brabander M, De Cree J, D\u2019Hooge R, Geerts H, Verhaegen H, De Deyn PP (1999) Unchanged levels of interleukins, neopterin, interferon-\u03b3 and tumor necrosis factor-\u03b1 in cerebrospinal fluid of patients with dementia of the Alzheimer type. Neurochem Int 34: 523\u2013530","journal-title":"Neurochem Int"},{"key":"11080231702_CR18","first-page":"339","volume-title":"Cerebrospinal fluid in diseases of the nervous system","author":"RA Fishman","year":"1992","unstructured":"Fishman RA (1992) Cerebrospinal fluid in diseases of the nervous system, 2nd edn. Saunders, Philadelphia, p 339","edition":"2nd edn"},{"key":"11080231702_CR19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini mental state\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189\u2013198","journal-title":"J Psychiatr Res"},{"key":"11080231702_CR20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/eji.1830190418","volume":"19","author":"K Frei","year":"1989","unstructured":"Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A (1989) On the cellular source and function of interleukin-6 produced in the central nervous system in viral diseases. Eur J Immunol 19: 689\u2013694","journal-title":"Eur J Immunol"},{"key":"11080231702_CR21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF02279767","volume":"240","author":"L Fr\u00f6lich","year":"1991","unstructured":"Fr\u00f6lich L, Kornhuber J, Ihl R, Fritze J, Maurer K, Riederer P (1991) Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF\/serum ratios of albumin and IgG. Eur Arch Psychiatry Clin Neurosci 240: 363\u2013366","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"11080231702_CR22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000008157","volume":"43","author":"R Fukuyama","year":"2000","unstructured":"Fukuyama R, Mizuno T, Mori S, Yanagisawa K, Nakajima K, Fushiki S (2000) Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer\u2019s disease. Eur Neurol 43: 161\u2013169","journal-title":"Eur Neurol"},{"key":"11080231702_CR23","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0149-7634(98)00058-X","volume":"23","author":"E Gahtan","year":"1999","unstructured":"Gahtan E, Overmier JB (1999) Inflammatory pathogenesis in Alzheimer\u2019s disease: biological mechanisms and cognitive sequeli. Neurosci Biobehav Rev 23: 615\u2013633","journal-title":"Neurosci Biobehav Rev"},{"issue":"Suppl","key":"11080231702_CR24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-3-7091-6467-9_19","volume":"53","author":"D Galasko","year":"1998","unstructured":"Galasko D (1998) Cerebrospinal fluid levels of A\u03b242 and tau: potential markers of Alzheimer\u2019s disease. J Neural Transm [Suppl] 53: 209\u2013221","journal-title":"J Neural Transm"},{"key":"11080231702_CR25","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archneur.55.7.937","volume":"55","author":"D Galasko","year":"1998","unstructured":"Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P (1998) High cerebrospinal fluid tau and low amyloid \u03b242 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol 55: 937\u2013945","journal-title":"Arch Neurol"},{"key":"11080231702_CR26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0165-5728(94)90134-1","volume":"51","author":"BD Gitter","year":"1994","unstructured":"Gitter BD, Regoli D, Howbert JJ, Glasebrook AL, Waters DC (1994) Interleukin-6 secretion from human astrocytoma cells induced by substance P. J Neuroimmunol 51: 101\u2013108","journal-title":"J Neuroimmunol"},{"key":"11080231702_CR27","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0166-2236(93)90078-Z","volume":"16","author":"M Goedert","year":"1993","unstructured":"Goedert M (1993) Tau protein and the neurofibrillary pathology of Alzheimer\u2019s disease. Trends Neurosci 16: 460\u2013465","journal-title":"Trends Neurosci"},{"key":"11080231702_CR28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3940(98)00904-5","volume":"259","author":"AJ Green","year":"1999","unstructured":"Green AJ, Harvey RJ, Thompson EJ, Rossor MN (1999) Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer\u2019s disease. Neurosci Lett 259: 133\u2013135","journal-title":"Neurosci Lett"},{"issue":"Suppl","key":"11080231702_CR29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-3-7091-6846-2_12","volume":"51","author":"W Gsell","year":"1997","unstructured":"Gsell W, Strein I, Krause U, Riederer P (1997) Neurochemical abnormalities in Alzheimer\u2019s disease and Parkinson\u2019s disease \u2014 a comparative review. J Neural Transm [Suppl] 51: 145\u2013159","journal-title":"J Neural Transm"},{"key":"11080231702_CR30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0304-3940(97)13477-2","volume":"224","author":"S Hahne","year":"1997","unstructured":"Hahne S, Nordstedt C, Ahlin A, Nyb\u00e4ck H (1997) Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer\u2019s disease and healthy controls. Neurosci Lett 224: 99\u2013102","journal-title":"Neurosci Lett"},{"key":"11080231702_CR31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0306-4522(91)90132-8","volume":"40","author":"T Hama","year":"1991","unstructured":"Hama T, Kushima Y, Miyamoto M, Kubota M, Takei N, Hatanaka H (1991) Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons. Neuroscience 40: 445\u2013452","journal-title":"Neuroscience"},{"key":"11080231702_CR32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3940(97)00379-0","volume":"228","author":"H Hampel","year":"1997","unstructured":"Hampel H, Schoen D, Schwarz MJ, K\u00f6tter HU, Schneider C, Sunderland T, Dukoff R, Levy J, Padberg F, Stubner S, Buch K, M\u00fcller N, M\u00f6ller HJ (1997) Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer\u2019s disease. Neurosci Lett 228: 143\u2013146","journal-title":"Neurosci Lett"},{"key":"11080231702_CR33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00002093-199903000-00002","volume":"13","author":"H Hampel","year":"1999","unstructured":"Hampel H, K\u00f6tter HU, Padberg F, K\u00f6rschenhausen DA, M\u00f6ller HJ (1999) Oligoclonal bands and blood-cerebrospinal fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis. Alzheimer Dis Assoc Disord 13: 9\u201319","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"11080231702_CR34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1007516210548","volume":"25","author":"C Hesse","year":"2000","unstructured":"Hesse C, Larsson H, Fredman P, Minthon L, Andreason N, Davidsson P, Blennow K (2000) Measurement of apolipoprotein E (apoE) in cerebrospinal fluid. Neurochem Res 25: 511\u2013517","journal-title":"Neurochem Res"},{"key":"11080231702_CR35","first-page":"414","volume":"37","author":"C Flock","year":"1995","unstructured":"Flock C, Golombowski S, Naser W, M\u00fcller-Spahn F (1995) Increased levels of tau protein in cerebrospinal fluid of patients with Alzheimer\u2019s disease \u2013 correlation with degree of cognitive impairment. Ann Neurol 37: 414\u2013415","journal-title":"Ann Neurol"},{"key":"11080231702_CR36","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/BF00571510","volume":"89","author":"M H\u00fcll","year":"1995","unstructured":"H\u00fcll M, Strauss S, Volk B, Berger M, Bauer J (1995) Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer\u2019s disease patients. Acta Neuropathol 89: 544\u2013551","journal-title":"Acta Neuropathol"},{"key":"11080231702_CR37","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","volume":"52","author":"F Hulstaert","year":"1999","unstructured":"Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M, De Deyn PP, Bancher C, Cras P, Wiltfang J, Mehta PD, Iqbal K, Pottel H, Vanmechelen E, Vanderstichele H (1999) Improved discrimination of Alzheimer\u2019s disease patients using \u03b2-amyloid(1\u201342) and tau levels in CSF. Neurology 52: 1555\u20131562","journal-title":"Neurology"},{"key":"11080231702_CR38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(99)00476-0","volume":"270","author":"K Ishiguro","year":"1999","unstructured":"Ishiguro K, Ohno H, Arai H, Yamaguchi H, Urakami K, Park JM, Sato K, Kohno H, Imahori K (1999) Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer\u2019s disease. Neurosci Lett 270: 91\u201394","journal-title":"Neurosci Lett"},{"issue":"Suppl","key":"11080231702_CR39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-7091-6467-9_9","volume":"53","author":"KA Jellinger","year":"1998","unstructured":"Jellinger KA (1998) The neuropathological diagnosis of Alzheimer disease. J Neural Transm [Suppl] 53: 97\u2013118","journal-title":"J Neural Transm"},{"key":"11080231702_CR40","first-page":"682","volume":"111","author":"KA Jellinger","year":"1999","unstructured":"Jellinger KA (1999) What is new in degenerative dementia disorders? Wien Klin Wochenschr 111: 682\u2013704","journal-title":"Wien Klin Wochenschr"},{"key":"11080231702_CR41","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1212\/WNL.54.7.1498","volume":"54","author":"PJ Kahle","year":"2000","unstructured":"Kahle PJ, Jakowec M, Teipel SH, Hampel H, Pethinger GM, Di Monte DA, Silverberg GD, M\u00f6ller HJ, Yesavage JA, Trinklenberg JR, Shooter EM, Murphy GM (2000) Combined assessment of tau and neuronal thread protein in Alzheimer\u2019s disease CSF. Neurology 54: 1498\u20131504","journal-title":"Neurology"},{"key":"11080231702_CR42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410440108","volume":"44","author":"M Kanai","year":"1998","unstructured":"Kanai M, Matsubara E, Isoe K, Urakami K, Nakashima K, Arai H, Sasaki H, Abe K, Iwatsubo T, Kosaka T, Watanabe M, Tomidokoro Y, Shizuka M, Mizushima K, Nakamura T, Igeta Y, Ikeda Y, Amari M, Kawarabayashi T, Ishiguro K, Harigaya Y, Wakabayashi K, Okamoto K, Hirai S, Shoji M (1998) Longitudinal study of cerebrospinal fluid levels of tau, A\u03b2(1\u201340), and A\u03b2(1\u201342)(43) in Alzheimer\u2019s disease: a study in Japan. Ann Neurol 44: 17\u201326","journal-title":"Ann Neurol"},{"key":"11080231702_CR43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0197-4580(87)90053-4","volume":"8","author":"AD Kay","year":"1987","unstructured":"Kay AD, May C, Papadopoulos NM, Costello R, Atack JR, Luxenberg JS, Cutler NR, Rapoport SI (1987) CSF and serum concentrations of albumin and IgG in Alzheimer\u2019s disease. Neurobiol Aging 8: 21\u201325","journal-title":"Neurobiol Aging"},{"key":"11080231702_CR44","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.1073\/pnas.88.16.7247","volume":"88","author":"NW Kowall","year":"1991","unstructured":"Kowall NW, Beal MF, Busciglio J, Duffy LK, Yankner BA (1991) An in vivo model for the neurodegenerative effects of \u03b2 amyloid and protection by substance P. Proc Natl Acad Sci USA 88: 7247\u20137251","journal-title":"Proc Natl Acad Sci USA"},{"key":"11080231702_CR45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00002093-199809000-00016","volume":"12","author":"AS Lanzrein","year":"1998","unstructured":"Lanzrein AS, Johnston CM, Perry VH, Jobst KA, King EM, Smith AD (1998) Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1\u03b2, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-\u03b1, the soluble tumor necrosis factor receptors I and II, and \u03b11-antichymotrypsin. Alzheimer Dis Assoc Disord 12: 215\u2013227","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"11080231702_CR46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3940(96)12774-9","volume":"212","author":"D Lefranc","year":"1996","unstructured":"Lefranc D, Vermersch P, Dallongeville J, Daems-Monpeurt C, Petit H, Delacourte A (1996) Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer\u2019s disease. Neurosci Lett 212: 91\u201394","journal-title":"Neurosci Lett"},{"key":"11080231702_CR47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0022-510X(85)90121-2","volume":"67","author":"A Leonardi","year":"1985","unstructured":"Leonardi A, Gandolfo C, Caponnetto C, Arata L, Vecchia R (1985) The integrity of the blood-brain barrier in Alzheimer\u2019s type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid. J Neurol Sci 67: 253\u2013261","journal-title":"J Neurol Sci"},{"key":"11080231702_CR48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3940(97)00429-1","volume":"229","author":"Lindh M","year":"1997","unstructured":"Lindh M, Blomberg M, Jensen M, Basun H, Lannfelt L, Engvall B, Scharnagl H, M\u00e4rz W, Wahlund LO, Cowburn RF (1997) Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer\u2019s disease patients are increased at follow up and show a correlation with levels of tau protein. Neurosci Lett 229: 85\u201388","journal-title":"Neurosci Lett"},{"key":"11080231702_CR49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0149-7634(05)80206-4","volume":"16","author":"P Malek-Ahmadi","year":"1992","unstructured":"Malek-Ahmadi P (1992) Substance P and neuropsychiatry disorders: an overview. Neurosci Biobehav Rev 16: 365\u2013369","journal-title":"Neurosci Biobehav Rev"},{"key":"11080231702_CR50","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0165-5728(93)90197-7","volume":"48","author":"M Martinez","year":"1993","unstructured":"Martinez M, Frank A, Hernanz A (1993) Relationship of interleukin-1\u03b2 and \u03b22-microglobulin with neuropeptides in cerebrospinal fluid of patients with dementia of the Alzheimer type. J Neuroimmunol 48: 235\u2013240","journal-title":"J Neuroimmunol"},{"key":"11080231702_CR51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(97)00886-0","volume":"239","author":"P M\u00e4rz","year":"1997","unstructured":"M\u00e4rz P, Heese K, Hock C, Golombowksi S, M\u00fcller-Spahn F, Rose-John S, Otten U (1997) Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer\u2019s disease patients. Neurosci Lett 239: 29\u201332","journal-title":"Neurosci Lett"},{"key":"11080231702_CR52","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1056\/NEJM199802193380804","volume":"338","author":"R Mayeux","year":"1998","unstructured":"Mayeux R, Saunders AM, Shea S, Mirra S, Evans D, Roses AD, Hyman BT, Grain B, Tang MX, Phelps CH (1998) Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer\u2019s disease. N Engl J Med 338: 506\u2013511","journal-title":"N Engl J Med"},{"key":"11080231702_CR53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00002093-199408030-00001","volume":"8","author":"PL McGeer","year":"1994","unstructured":"McGeer PL, Rogers J, McGeer EG (1994) Neuroimmune mechanisms in Alzheimer disease pathogenesis. Alzheimer Dis Assoc Disord 8: 149\u2013158","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"11080231702_CR54","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34: 939\u2013944","journal-title":"Neurology"},{"key":"11080231702_CR55","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0404.1991.tb04940.x","volume":"84","author":"P Mecocci","year":"1991","unstructured":"Mecocci P, Parnetti L, Reboldi GP, Santucci C, Gaiti A, Ferri C, Gernini I, Romagnoli M, Cadini D, Senin U (1991) Blood-brain-barrier in a geriatric population: barrier function in degenerative and vascular dementias. Acta Neurol Scand 84: 210\u2013213","journal-title":"Acta Neurol Scand"},{"key":"11080231702_CR56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-510X(96)00234-1","volume":"145","author":"A Merched","year":"1997","unstructured":"Merched A, Blain H, Visvikis S, Herbeth B, Jeandel C, Siest G (1997) Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer\u2019s disease. J Neurol Sci 145: 33\u201339","journal-title":"J Neurol Sci"},{"key":"11080231702_CR57","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.410380413","volume":"38","author":"R Motter","year":"1995","unstructured":"Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D, Chang L, Miller B, Clark C, Green R, Olson D, Southwick P, Wolfert R, Munroe B, Lieberburg I, Seubert P, Schenk D (1995) Reduction of \u03b2-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer\u2019s disease. Ann Neurol 38: 643\u2013648","journal-title":"Ann Neurol"},{"key":"11080231702_CR58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000017050","volume":"9","author":"Z Nagy","year":"1998","unstructured":"Nagy Z, Esiri MM, Hindley NJ, Joachim C, Morris JH, King EM, McDonald B, Litchfield S, Barnetson L, Jobst KA, Smith AD (1998) Accuracy of clinical operational diagnostic criteria for Alzheimer\u2019s disease in relation to different pathological diagnostic protocols. Dement Geriatr Cogn Disord 9: 219\u2013226","journal-title":"Dement Geriatr Cogn Disord"},{"key":"11080231702_CR59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","volume":"541","author":"Y Namba","year":"1991","unstructured":"Namba Y, Tomanaga M, Kawasaki H, Otomo E, Ikeda K (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer\u2019s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541: 163\u2013166","journal-title":"Brain Res"},{"key":"11080231702_CR60","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(87)91413-9","volume":"ii","author":"MW Nijsten","year":"1987","unstructured":"Nijsten MW, de Groot ER, ten Duis HJ, Klasen HJ, Hack CE, Aarden LA (1987) Serum levels of interleukin-6 and acute phase response. Lancet ii: 921","journal-title":"Lancet"},{"key":"11080231702_CR61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archneur.1996.00550020105022","volume":"53","author":"T Pirttil\u00e4","year":"1996","unstructured":"Pirttil\u00e4 T, Mehta PD, Soininen H, Kim KS, Heinonen O, Palj\u00e4rvi L, Kosunen O, Riekkinen P, Wisniewski HM (1996) Cerebrospinal fluid concentrations of soluble amyloid \u03b2-protein and apolipoprotein E in patients with Alzheimer\u2019s disease: correlations with amyloid load in the brain. Arch Neurol 53: 189\u2013193","journal-title":"Arch Neurol"},{"key":"11080231702_CR62","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0166-2236(94)90156-2","volume":"17","author":"J Pokier","year":"1994","unstructured":"Pokier J (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer\u2019s disease. Trends Neurosci 17: 525\u2013530","journal-title":"Trends Neurosci"},{"key":"11080231702_CR63","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0009-8981(87)90250-6","volume":"163","author":"H Reiber","year":"1987","unstructured":"Reiber H, Felgenhauer K (1987) Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system.. Clin Chim Acta 163: 319\u2013328","journal-title":"Clin Chim Acta"},{"key":"11080231702_CR64","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/jnnp.60.4.452","volume":"60","author":"N R\u00f6sier","year":"1996","unstructured":"R\u00f6sier N, Wichart I, Jellinger KA (1996a) Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 60: 452\u2013454","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11080231702_CR65","first-page":"237","volume":"60","author":"N R\u00f6sier","year":"1996","unstructured":"R\u00f6sier N, Wichart I, Jellinger KA (1996b) Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 60: 237\u2013238","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11080231702_CR66","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.52.3.547","volume":"52","author":"SC Samuels","year":"1999","unstructured":"Samuels SC, Silverman JM, Marin DB, Peskind ER, Younki SG, Greenberg DA, Schnur E, Santoro J, Davis KL (1999) CSF \u03b2-amyloid, cognition, and ApoE genotype in Alzheimer\u2019s disease. Neurology 52: 547\u2013551","journal-title":"Neurology"},{"key":"11080231702_CR67","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-510X(98)00122-1","volume":"158","author":"M Shoji","year":"1998","unstructured":"Shoji M, Matsubara E, Kanai M, Watanabe M, Nakamura T, Tomidokoro Y, Shizuka M, Wakabayashi K, Igeta Y, Ikeda Y, Mizushima K, Amari M, Ishiguro K, Kawarabayashi T, Harigaya Y, Okamoto K, Hirai S (1998) Combination assay of CSF tau, A\u03b2(1\u201340) and A\u03b2(1\u201342)(43) as a biochemical marker of Alzheimer\u2019s disease. J Neurol Sci 158: 134\u2013140","journal-title":"J Neurol Sci"},{"key":"11080231702_CR68","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/archneur.1997.00550150029012","volume":"54","author":"I Skoog","year":"1997","unstructured":"Skoog I, Hesse C, Fredman P, Andreasson LA, Palmertz B, Blennow K (1997) Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Arch Neurol 54: 267\u2013272","journal-title":"Arch Neurol"},{"key":"11080231702_CR69","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1212\/WNL.50.4.966","volume":"50","author":"I Skoog","year":"1998","unstructured":"Skoog I, Wallin A, Fredman P, Hesse C, Aevarsson O, Karlsson I, Gottfries CG, Blennow K (1998) A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer\u2019s disease and vascular dementia. Neurology 50: 966\u2013971","journal-title":"Neurology"},{"key":"11080231702_CR70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00002093-199408010-00006","volume":"8","author":"GW Small","year":"1994","unstructured":"Small GW, Rosenthal M, Tourtellotte WW (1994) Central nervous system IgG synthesis rates in Alzheimer disease: possible differences in early-onset and late-onset subgroups. Alzheimer Dis Assoc Disord 8: 29\u201337","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"11080231702_CR71","unstructured":"Statistica for Windows. Computer program manual (1995) StatSoft Inc, Tulsa, USA"},{"key":"11080231702_CR72","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-3223(99)00301-7","volume":"47","author":"PH St George-Hyslop","year":"2000","unstructured":"St George-Hyslop PH (2000) Molecular genetics of Alzheimer\u2019s disease. Biol Psychiatry 47: 183\u2013199","journal-title":"Biol Psychiatry"},{"key":"11080231702_CR73","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0006-3223(99)00143-2","volume":"46","author":"T Sunderland","year":"1999","unstructured":"Sunderland T, Wolozin B, Galasko D, Levy J, Dukoff R, Bahro M, Lasser R, Motter R, Lehtim\u00e4ki T, Seubert P (1999) Longitudinal stability of CSF tau in Alzheimer patients. Biol Psychiatry 46: 750\u2013755","journal-title":"Biol Psychiatry"},{"key":"11080231702_CR74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0304-3940(00)00767-9","volume":"280","author":"T Tapiola","year":"2000","unstructured":"Tapiola T, Pirttil\u00e4 T, Mikkonen M, Mehta PD, Alafuzoff I, Koivisto K, Soininen H (2000) Three-year-follow-up of cerebrospinal fluid tau, \u03b2-amyloid 42 and 40 concentrations in Alzheimer\u2019s disease. Neurosci Lett 280: 119\u2013122","journal-title":"Neurosci Lett"},{"key":"11080231702_CR75","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jnnp.59.3.280","volume":"59","author":"RE Tato","year":"1995","unstructured":"Tato RE, Frank A, Hernanz A (1995) Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 59: 280\u2013283","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11080231702_CR76","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000213799","volume":"42","author":"G Valenti","year":"1996","unstructured":"Valenti G (1996) Neuropeptide changes in dementia: pathogenic implications and diagnostic value. Gerontology 42: 241\u2013256","journal-title":"Gerontology"},{"key":"11080231702_CR77","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1471-4159.1993.tb09823.x","volume":"61","author":"M Vandermeeren","year":"1993","unstructured":"Vandermeeren M, Mercken M, Vanmechelen E, Six J, van de Voorde A, Martin JJ, Cras P (1993) Detection of tau proteins in normal and Alzheimer\u2019s disease cerebrospinal fluid with a sensitive enzyme-linked immunosorbent assay. J Neurochem 61: 1828\u20131834","journal-title":"J Neurochem"},{"key":"11080231702_CR78","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0304-3940(94)90677-7","volume":"172","author":"WA Gool Van","year":"1994","unstructured":"Van Gool WA, Schenk DB, Bolhuis PA (1994) Concentrations of amyloid-\u03b2-protein in cerebrospinal fluid increase with age in patients free from neurodegenerative disease. Neurosci Lett 172: 122\u2013124","journal-title":"Neurosci Lett"},{"key":"11080231702_CR79","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0304-3940(92)90444-C","volume":"135","author":"T Wisniewski","year":"1992","unstructured":"Wisniewski T, Frangione B (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 135: 235\u2013238","journal-title":"Neurosci Lett"},{"key":"11080231702_CR80","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/bbrc.1993.1423","volume":"192","author":"T Wisniewski","year":"1993","unstructured":"Wisniewski T, Golabek A, Matsubara E, Ghiso J, Frangione B (1993) Apolipoprotein E: binding to soluble Alzheimer\u2019s \u03b2-amvloid. Biochem Biophys Res Comm 192: 359\u2013365","journal-title":"Biochem Biophys Res Comm"},{"key":"11080231702_CR81","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0006-8993(93)91327-O","volume":"629","author":"JA Wood","year":"1993","unstructured":"Wood JA, Wood PL, Ryan R, Graff-Radford NR, Pilapil C, Robitaille Y, Quirion R (1993) Cytokine indices in Alzheimer\u2019s temporal cortex: no changes in mature IL- 1\u03b2 or IL-1RA but increases in the associated acute phase proteins IL-6, \u03b12-macroglobulin and C-reactive protein. Brain Res 629: 245\u2013252","journal-title":"Brain Res"},{"key":"11080231702_CR82","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0304-3940(95)11318-Q","volume":"186","author":"K Yamada","year":"1995","unstructured":"Yamada K, Kono K, Umegaki H, Yamada K, Iguchi A, Fukatsu T, Nakashima N, Nishiwaki H, Shimada Y, Sugita Y, Yamamoto T, Hasegawa T, Nabeshima T (1995) Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia. Neurosci Lett 186: 219\u2013221","journal-title":"Neurosci Lett"},{"key":"11080231702_CR83","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.2218531","volume":"250","author":"BA Yankner","year":"1990","unstructured":"Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid \u03b2 protein: reversal by tachykinin neuropeptides. Science 250: 279\u2013282","journal-title":"Science"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s007020170091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s007020170091\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s007020170091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:39:51Z","timestamp":1559104791000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s007020170091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["11080231702"],"URL":"https:\/\/doi.org\/10.1007\/s007020170091","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}